Edgewise Therapeutics Stock (NASDAQ:EWTX), Quotes and News Summary

Q: What sector and industry does Edgewise Therapeutics (EWTX) operate in?

Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Edgewise Therapeutics Stock (NASDAQ: EWTX) stock price, news, charts, stock research, profile.

Open	$19.740
Close	$19.520
Volume / Avg.	545.136K / 733.435K
Day Range	19.440 - 20.120
52 Wk Range	5.120 - 20.900
Market Cap	$1.823B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	70
Short Interest	9.02%
Days to Cover	9.34

Recent News

Insiders Buying Edgewise Therapeutics And 2 Other Stocks

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

Avi Kapoor

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Avi Kapoor

What's Going On With Edgewise Therapeutics Stock?

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) shares are trading higher Friday after the company announced the pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Edgewise Therapeutics (EWTX) stock?

You can purchase shares of Edgewise Therapeutics (NASDAQ: EWTX) through any online brokerage.

View our list of the best stock brokerages.

Who are Edgewise Therapeutics's (EWTX) competitors?

Other companies in Edgewise Therapeutics’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).

What is the target price for Edgewise Therapeutics (EWTX) stock?

The latest price target for Edgewise Therapeutics (NASDAQ: EWTX) was reported by RBC Capital on Monday, April 22, 2024. The analyst firm set a price target for 32.00 expecting EWTX to rise to within 12 months (a possible 63.93% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for Edgewise Therapeutics (EWTX)?

The stock price for Edgewise Therapeutics (NASDAQ: EWTX) is $19.52 last updated May 3, 2024 at 4:04 PM EDT.

Does Edgewise Therapeutics (EWTX) pay a dividend?

There are no upcoming dividends for Edgewise Therapeutics.

When is Edgewise Therapeutics (NASDAQ:EWTX) reporting earnings?

Edgewise Therapeutics’s Q1 earnings are confirmed for Friday, May 17, 2024.

Is Edgewise Therapeutics (EWTX) going to split?

There is no upcoming split for Edgewise Therapeutics.

What sector and industry does Edgewise Therapeutics (EWTX) operate in?

Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-